Dolby Laboratories stock price target raised to $114 by Tigress Financial

Published 15/08/2025, 15:38
Dolby Laboratories stock price target raised to $114 by Tigress Financial

Investing.com - Tigress Financial Partners has raised its price target on Dolby Laboratories (NYSE:DLB) to $114.00 from its previous target, while maintaining a Buy rating on the stock. According to InvestingPro data, the stock is currently trading below its Fair Value, suggesting potential upside opportunity. The company maintains strong financials with an impressive gross profit margin of 88.5%.

The research firm cited Dolby’s solid growth in licensing revenues and strong adoption across key markets as primary factors behind the increased target. Tigress Financial also highlighted the company’s resilient gross margins and ongoing innovation in immersive media as elements that will continue to drive long-term growth. InvestingPro analysis reveals the company has maintained dividend payments for 12 consecutive years, with a current yield of 1.82%.

Dolby’s high-margin licensing business model, coupled with its immersive audio and video enhancement technology across various devices and platforms, is expected to drive accelerating business performance trends, according to the research note. These trends include increasing return on capital and greater economic profit. The company’s strong financial position is evidenced by its healthy balance sheet, with more cash than debt and liquid assets exceeding short-term obligations. For deeper insights into Dolby’s financial health and growth potential, access the comprehensive Pro Research Report available on InvestingPro.

The audio technology company is expanding its footprint in the automotive sector, transforming vehicles into immersive entertainment hubs. This represents a major growth vertical in what Tigress describes as a multibillion-dollar addressable market.

Tigress Financial also noted that Dolby is actively embedding AI across all of its platforms, driven by Dolby OptiView to deliver real-time, ultra-low-latency, high-quality streaming and gaming experiences. The firm has included Dolby Laboratories on its Research Focus List and Focus Opportunity Portfolio.

In other recent news, Dolby Laboratories reported impressive third-quarter earnings for 2025, surpassing both revenue and earnings per share (EPS) forecasts. The company achieved an EPS of $0.78, exceeding the projected $0.71. Dolby also generated $316 million in revenue, surpassing the forecasted $305.23 million. These results indicate a strong performance for the company in the recent quarter. Despite the positive earnings report, Dolby’s stock experienced a slight dip in after-hours trading. The company’s financial results reflect mixed investor sentiment. These developments are crucial for investors to consider when evaluating Dolby Laboratories.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.